Flurbiprofen
| Flurbiprofen | |
|---|---|
| Salts [] | |
|---|---|
| Sodium flurbiprofen | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 244.26 g/mol [1] |
| Melting point | 110-111 °C [1] |
| Solubility | 8 mg/L (at 22 °C) [1] |
| Predicted LogP | 4.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C15H13FO2 |
| IUPAC name | 2-(3-fluoro-4-phenylphenyl)propanoic acid |
| SMILES | CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O |
| InChI | InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18) |
| InChIKey | SYTBZMRGLBWNTM-UHFFFAOYSA-N |
| CAS number | 5104-49-4 |
| UNII | 5GRO578KLP |
| PubChem CID | 3394 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 4.7-5.7 hours |
| Metabolism | Liver (CYP2C9) |
| Excretion | Kidney |
| Routes of administration | By mouth |
| Toxicity [] | |
|---|---|
| LD50 | Dog: - Oral: 10 mg/kg [1] |
Flurbiprofen (also known as Ansaid, Froben, Antadys, Flurbiprofene, Flubiprofen, Cebutid, Zepolas, Flurbiprofeno, 2-(2-fluorobiphenyl-4-yl)propanoic acid or Flurbiprofenum) is a nonsteroidal anti-inflammatory drug substance of the alcohol class.
Chemistry
Salts []
Stereochemistry []
Flurbiprofen is a racemic mixture of the enantiomers (optical activity ( + / - )).
| Stereoisomerism |
|---|
| Stereoisomers from PubChem |
Druglikeness
Lipinski's rule of five
Flurbiprofen matches Lipinski's rule of five.Pharmacology
ATC Classification
- musculo-skeletal system (M)
- antiinflammatory and antirheumatic products (M01)
- antiinflammatory and antirheumatic products, non-steroids (M01A)
- propionic acid derivatives (M01AE)
- flurbiprofen (M01AE09)
- topical products for joint and muscular pain (M02)
- topical products for joint and muscular pain (M02A)
- antiinflammatory preparations, non-steroids for topical use (M02AA)
- flurbiprofen (M02AA19)
- respiratory system (R)
- throat preparations (R02)
- throat preparations (R02A)
- other throat preparations (R02AX)
- (R02AX01)
- flurbiprofen (R02AX01)
- sensory organs (S)
- ophthalmologicals (S01)
- antiinflammatory agents (S01B)
- antiinflammatory agents, non-steroids (S01BC)
- flurbiprofen (S01BC04)
MeSH Classification
- analgesics (M0001067)
- anti-inflammatory agents, non-steroidal (M0001335)
- cyclooxygenase inhibitors (M0025664)
Mechanism of action []
Similar to other NSAIAs, the anti-inflammatory effect of flurbiprofen occurs via reversible inhibition of cyclooxygenase (COX), the enzyme responsible for the conversion of arachidonic acid to prostaglandin G2 (PGG2) and PGG2 to prostaglandin H2 (PGH2) in the prostaglandin synthesis pathway. This effectively decreases the concentration of prostaglandins involved in inflammation, pain, swelling and fever. Flurbiprofen is a non-selective COX inhibitor and inhibits the activity of both COX-1 and -2. It is also one of the most potent NSAIAs in terms of prostaglandin inhibitory activity. [1]
Interactions []
Medical side effects []
235 side effects listed on drug labels in SIDER 4.1 (flurbiprofen).
- Abdominal pain
- Gastrointestinal pain
- Agranulocytosis
- Albuminuria
- Alopecia
- Amblyopia
- Amnesia
- Anaphylactic shock
- Anaemia
- Aplastic anaemia
- Haemolytic anaemia
- Angina pectoris
- Angioedema
- Decreased appetite
- Anxiety
- Arrhythmia
- Arthritis
- Asthenia
- Asthma
- Ataxia
- Blepharitis
- Bronchitis
- Cholecystitis
- Colitis
- Coma
- Infection
- Confusional state
- Feeling abnormal
- Malaise
- Conjunctivitis
- Constipation
- Corneal opacity
- Cystitis
- Bladder pain
- Cystitis noninfective
- Libido decreased
- Disturbance in sexual arousal
- Dermatitis exfoliative
- Diarrhoea
- Diplopia
- Dizziness
- Syncope
- Somnolence
- Dyspepsia
- Heartburn
- Dyspnoea
- Dysuria
- Ear disorder
- Ecchymosis
- Eczema
- Oedema
- Enteritis
- Eosinophilia
- Toxic epidermal necrolysis
- Epistaxis
- Eructation
- Erythema multiforme
- Stevens-Johnson syndrome
- Oesophageal disorder
- Oesophagitis
- Dermatitis
- Rash
- Body temperature increased
- Fever chills
- Fibrosis
- Flatulence
- Gastritis
- Gastroenteritis
- Gastrointestinal haemorrhage
- Gingival bleeding
- Gingivitis
- Glaucoma
- Glossitis
- Hallucination
- Headache
- Cardiac failure congestive
- Haematemesis
- Haematuria
- Haemorrhage
- Haemoglobin
- Hepatitis
- Herpes simplex
- Herpes zoster
- Hyperglycaemia
- Hyperkalaemia
- Hypersensitivity
- Hypertension
- Hyperventilation
- Hyphaema
- Hypotension
- Incontinence
- Inflammatory bowel disease
- Influenza
- Jaundice
- Jaundice cholestatic
- Arthropathy
- Osteoarthritis
- Keratitis
- Nephrolithiasis
- Laryngitis
- Leukocytosis
- Leukopenia
- Vaginal discharge
- Lung disorder
- Breast pain
- Melaena
- Meningitis
- Meningitis aseptic
- Hypertonia
- Mydriasis
- Myocardial infarction
- Acute coronary syndrome
- Nail disorder
- Nausea
- Tubulointerstitial nephritis
- Nervousness
- Tension
- Neuralgia
- Neutropenia
- Oliguria
- Palpitations
- Pancreatitis
- Pancytopenia
- Paraesthesia
- Peptic ulcer
- Tooth abscess
- Petechiae
- Pharyngitis
- Phlebitis
- Pneumonia
- Polyuria
- Urine output increased
- Prostatic disorder
- Proteinuria
- Protein urine present
- Pruritus
- Pulmonary embolism
- Pulmonary infarction
- Purpura
- Vascular purpura
- Pyuria
- Renal failure
- Retinal haemorrhage
- Rhinitis
- Scleritis
- Seborrhoeic dermatitis
- Convulsion
- Sinusitis
- Skin ulcer
- Speech disorder
- Stomatitis
- Cerebrovascular accident
- Subarachnoid haemorrhage
- Hyperhidrosis
- Shock
- Loss of consciousness
- Tachycardia
- Tenosynovitis
- Thirst
- Thrombocytopenia
- Tinnitus
- Tremor
- Ulcer
- Urethritis
- Urethritis noninfective
- Urinary tract infection
- Urticaria
- Uterine haemorrhage
- Vaginal inflammation
- Vaginal infection
- Angiopathy
- Vasculitis
- Vasodilation procedure
- Vertigo
- Vomiting
- Vulvovaginitis
- Dry mouth
- Optic neuritis
- Chills
- Hepatic failure
- Mood swings
- Affect lability
- Photophobia
- Migraine
- Bleeding time prolonged
- Diarrhoea haemorrhagic
- Electroencephalogram abnormal
- Gastrointestinal perforation
- Renal impairment
- Hyperreflexia
- Dry skin
- White blood cell disorder
- Endophthalmitis
- Ocular hyperaemia
- Iron deficiency anaemia
- Nail discolouration
- Discomfort
- Ill-defined disorder
- Emotional distress
- Myalgia
- Musculoskeletal discomfort
- Muscle twitching
- Increased appetite
- Respiratory depression
- Pulmonary function test decreased
- Euphoric mood
- Eye irritation
- Right ventricular failure
- Urine abnormality
- Urine analysis abnormal
- Hepatic enzyme increased
- Skin exfoliation
- Erectile dysfunction
- Sepsis
- Rectal haemorrhage
- Extrasystoles
- Photosensitivity reaction
- Abdominal distension
- Lymphadenopathy
- Anorectal discomfort
- Abdominal discomfort
- Cough
- Pain
- Drug interaction
- Blood uric acid increased
- Hyperuricaemia
- Cerebral ischaemia
- Insomnia
- Muscular weakness
- Gastrointestinal ulcer haemorrhage
- Deafness
- Hearing impaired
- Haemorrhagic disorder
- Parosmia
- Visual impairment
Indications
- Ankylosing spondylitis
- Bursitis
- Dysmenorrhoea
- Inflammation
- Intraocular pressure increased
- Leukocytosis
- Miosis
- Osteoarthritis
- Pain
- Rheumatoid arthritis
- Tendonitis
- Trauma
- Vasodilation
Subjective effects []
| 0xea / Flurbiprofen [] | |
|---|---|
Routes:
| |
| Pilz / Flurbiprofen [] | |
|---|---|
Routes:
| |
Legal status []
- Australia: Flurbiprofen is a S2 /S4.
- Canada: Flurbiprofen is Prescription only.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3394, Flurbiprofen. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3394
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Flurbiprofen. UNII: 5GRO578KLP. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/5GRO578KLP
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 08:00:38 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 08:00:34 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 08:00:34 |
| gsrs | ok | 2026-11-20 08:00:35 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014850) | 2026-11-20 08:00:34 |
| kegg | ok | 2026-11-20 08:00:38 |
| pubchem | ok | 2026-11-20 08:00:32 |
| missing (no r/tripreports posts mention it) | 2026-11-20 08:00:34 | |
| sider | ok | 2026-11-20 08:00:34 |
| structure | ok | 2026-11-20 08:00:34 |
| wikipedia | ok | 2026-11-20 08:00:34 |